INVENTIVA SA - ADR (IVA)

US46124U1079 - ADR

3.62  -0.2 (-5.24%)

After market: 3.77 +0.15 (+4.14%)

News Image
12 days ago - The Motley Fool

Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?

Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.

News Image
a month ago - Seeking Alpha

Inventiva stock drops after delay in Phase 3 NASH trial

Inventiva (IVA) stock plummeted as it announced a delay in its Phase 3 trial for NASH candidate lanifibranor due to an adverse event. Read more here.

News Image
7 months ago - Seeking Alpha

Inventiva announced €35.7M funding, eyes future raise to meet obligations (NASDAQ:IVA)

Biopharmaceutical firm Inventiva (IVA) Thursday announced a €35.7 million raise consisting of a capital increase and issuance of royalty certificates.The capital increase would be...

News Image
10 months ago - Seeking Alpha

Inventiva stock jumps on data for NASH drug (NASDAQ:IVA)

Inventiva (IVA) added ~25% Wednesday on positive data from a Phase 2 trial for its lead candidate lanifibranor targeted at nonalcoholic steatohepatitis. Read more here.

News Image
10 months ago - InvestorPlace

PLUG Stock Alert: Plug Power Announces New Avina Deal

Plug Power (PLUG) stock is on the move Wednesday after the EV charging company announced a deal with Avina Clean Hydrogen.

News Image
10 months ago - InvestorPlace

Why Is Cineverse (CNVS) Stock Down 24% Today?

Cineverse (CNVS) stock is falling on Wednesday after the company revealed the pricing of an $8 million public share offering.

News Image
10 months ago - InvestorPlace

Why Is Eastside Distilling (EAST) Stock Down 25% Today?

Eastside Distilling (EAST) stock is taking a beating on Wednesday after the company revealed plans to trade debt for equity.

News Image
10 months ago - InvestorPlace

Why Is Inventiva (IVA) Stock Up 38% Today

Inventiva (IVA) stock is rising higher on Wednesday following the release of positive results from a Phase II clinical trial.

News Image
10 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

It's time for another dive into the biggest pre-market stock movers as investors get ready to trade shares on Wednesday morning!

News Image
a year ago - Seeking Alpha

Inventiva draws down €25M tranche under contract with the EIB (NASDAQ:IVA)

Clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with non-alcoholic steatohepatitis, announced the...